Development and validation of CT-based nomograms for predicting recurrence and prognosis in gastrointestinal stromal tumor
- 4 November 2025
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (5) , 2292-2303
Abstract
Background This study analyzed preoperative CT features and postoperative pathological factors to predict recurrence after curative resection in primary gastrointestinal stromal tumor (GIST) and evaluate the prognostic validity of adjuvant therapy. Methods We retrospectively examined 718 patients with pathologically confirmed primary GISTs (mean age 57 ± 12.1 years; range, 14–86 years; 368 males, 350 females), who underwent R0 resection across two hospitals (internal set: n = 624; external set: n = 94). The internal set was randomly divided into training (n = 437) and validation cohorts (n = 187). Predictive efficacy of our nomogram was compared with the modified National Institutes of Health (MNIH) criterion using Kaplan–Meier analysis and multivariable Cox regression for recurrence-free survival (RFS). Results For recurrence prediction, AUC values for the CT model, combined nomogram (integrating CT features and pathological features), and MNIH criterion were 0.867/0.786/0.917 (training/validation/external test) and 0.890/0.810/0.953 versus 0.791/0.739/0.894, respectively. The combined nomogram demonstrated superior efficacy to the MNIH criterion across most probability thresholds (P < 0.001). The prognostic nomogram stratified patients into ‘high-recurrence’ and ‘low-recurrence’ groups with significantly divergent RFS. In the training cohort, the 1-, 3-, 5-, and 7-year RFS rates of these two groups were 95.9%, 85%, 73.5%, and 62.2% versus 100%, 99%, 95.5%, and 95.5%, respectively (P < 0.001). In the validation and external test cohorts, the nomograms were still significantly efficient (P < 0.001). Conclusions The combined nomogram provides improved noninvasive prediction of GIST recurrence and prognosis compared to the MNIH criterion. Trial registration Approved by the Institutional Review Board of West China Hospital, Sichuan University (No. 2020-249).Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- CT assessed morphological features can predict higher mitotic index in gastric gastrointestinal stromal tumorsEuropean Radiology, 2024
- Incidence and Survival Outcomes of Gastrointestinal Stromal TumorsJAMA Network Open, 2024
- The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registryGastric Cancer, 2023
- Risk stratification for 1- to 2-cm gastric gastrointestinal stromal tumors: visual assessment of CT and EUS high-risk features versus CT radiomics analysisEuropean Radiology, 2022
- Prognostic value of preoperative CT features for disease-free survival in patients with primary gastric gastrointestinal stromal tumors after resectionAbdominal Radiology, 2022
- Prediction of the Ki-67 expression level and prognosis of gastrointestinal stromal tumors based on CT radiomics nomogramInternational Journal of Computer Assisted Radiology and Surgery, 2022
- Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumorsEuropean Radiology, 2021
- Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumourEuropean Radiology, 2015
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal TumorJAMA, 2012
- Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumorsInternational Journal of Cancer, 2011